Alexandra MacLean's most recent trade in Avenue Therapeutics Inc was a trade of 170,000 COMMON STOCK, PAR VALUE $0.0001 done . Disclosure was reported to the exchange on Sept. 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avenue Therapeutics Inc | Alexandra MacLean | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 170,000 | 170,000 (1%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Avenue Therapeutics Inc | Alexandra MacLean | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 800,000 | 800,000 | - | - | Employee stock option (right to buy) |